Shaikh Kai J, Osio Victor A, Leeflang Mariska Mg, Shaikh Nader
Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Department of General Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Cochrane Database Syst Rev. 2020 Sep 10;9(9):CD009185. doi: 10.1002/14651858.CD009185.pub3.
In children with urinary tract infection (UTI), only those with pyelonephritis (and not cystitis) are at risk for developing long-term renal sequelae. If non-invasive biomarkers could accurately differentiate children with cystitis from children with pyelonephritis, treatment and follow-up could potentially be individualized. This is an update of a review first published in 2015.
The objectives of this review were to 1) determine whether procalcitonin (PCT), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) can replace the acute DMSA scan in the diagnostic evaluation of children with UTI; 2) assess the influence of patient and study characteristics on the diagnostic accuracy of these tests, and 3) compare the performance of the three tests to each other.
We searched MEDLINE, EMBASE, DARE, Web of Science, and BIOSIS Previews through to 17th December 2019 for this review. The reference lists of all included articles and relevant systematic reviews were searched to identify additional studies not found through the electronic search.
We only considered published studies that evaluated the results of an index test (PCT, CRP, ESR) against the results of an acute-phase Tc-dimercaptosuccinic acid (DMSA) scan (conducted within 30 days of the UTI) in children aged 0 to 18 years with a culture-confirmed episode of UTI. The following cut-off values were used for the primary analysis: 0.5 ng/mL for procalcitonin, 20 mg/L for CRP and 30 mm/hour for ESR.
Two authors independently applied the selection criteria to all citations and independently abstracted data. We used the bivariate model to calculate pooled random-effects pooled sensitivity and specificity values.
A total of 36 studies met our inclusion criteria. Twenty-five studies provided data for the primary analysis: 12 studies (1000 children) included data on PCT, 16 studies (1895 children) included data on CRP, and eight studies (1910 children) included data on ESR (some studies had data on more than one test). The summary sensitivity estimates (95% CI) for the PCT, CRP, ESR tests at the aforementioned cut-offs were 0.81 (0.67 to 0.90), 0.93 (0.86 to 0.96), and 0.83 (0.71 to 0.91), respectively. The summary specificity values for PCT, CRP, and ESR tests at these cut-offs were 0.76 (0.66 to 0.84), 0.37 (0.24 to 0.53), and 0.57 (0.41 to 0.72), respectively.
AUTHORS' CONCLUSIONS: The ESR test does not appear to be sufficiently accurate to be helpful in differentiating children with cystitis from children with pyelonephritis. A low CRP value (< 20 mg/L) appears to be somewhat useful in ruling out pyelonephritis (decreasing the probability of pyelonephritis to < 20%), but unexplained heterogeneity in the data prevents us from making recommendations at this time. The procalcitonin test seems better suited for ruling in pyelonephritis, but the limited number of studies and the marked heterogeneity between studies prevents us from reaching definitive conclusions. Thus, at present, we do not find any compelling evidence to recommend the routine use of any of these tests in clinical practice.
在患有尿路感染(UTI)的儿童中,只有那些患有肾盂肾炎(而非膀胱炎)的儿童有发生长期肾脏后遗症的风险。如果非侵入性生物标志物能够准确区分膀胱炎患儿和肾盂肾炎患儿,那么治疗和随访可能会更具个性化。这是2015年首次发表的一篇综述的更新。
本综述的目的是:1)确定降钙素原(PCT)、C反应蛋白(CRP)、红细胞沉降率(ESR)是否可以在UTI患儿的诊断评估中替代急性二巯基丁二酸(DMSA)扫描;2)评估患者和研究特征对这些检测诊断准确性的影响;3)比较这三项检测相互之间的性能。
我们检索了MEDLINE、EMBASE、DARE、科学网和BIOSIS Previews,直至2019年12月17日,以获取本综述的相关文献。我们检索了所有纳入文章的参考文献列表以及相关的系统评价,以识别通过电子检索未找到的其他研究。
我们仅考虑已发表的研究,这些研究评估了0至18岁经培养确诊为UTI的患儿中,指标检测(PCT、CRP、ESR)结果与急性期锝-二巯基丁二酸(DMSA)扫描结果(在UTI发生后30天内进行)的对比情况。主要分析采用以下临界值:降钙素原0.5 ng/mL、CRP 20 mg/L、ESR 30 mm/小时。
两位作者独立将入选标准应用于所有文献,并独立提取数据。我们使用双变量模型计算合并的随机效应合并敏感性和特异性值。
共有36项研究符合我们的纳入标准。25项研究提供了主要分析的数据:12项研究(1000名儿童)包含PCT数据,16项研究(1895名儿童)包含CRP数据,8项研究(1910名儿童)包含ESR数据(一些研究有不止一项检测的数据)。上述临界值下,PCT、CRP、ESR检测的汇总敏感性估计值(95%CI)分别为0.81(0.67至0.90)、0.93(0.86至0.96)和0.83(0.71至0.91)。这些临界值下,PCT、CRP和ESR检测的汇总特异性值分别为0.76(0.66至0.84)、0.37(0.24至0.53)和0.57(0.41至0.72)。
ESR检测似乎不够准确,无法帮助区分膀胱炎患儿和肾盂肾炎患儿。低CRP值(<20 mg/L)在排除肾盂肾炎方面似乎有些用处(将肾盂肾炎的可能性降低至<20%),但数据中存在无法解释的异质性,使我们目前无法提出建议。降钙素原检测似乎更适合确诊肾盂肾炎,但研究数量有限且研究之间存在显著异质性,使我们无法得出明确结论。因此,目前我们没有找到令人信服的证据来推荐在临床实践中常规使用这些检测中的任何一种。